Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

SLNO holding history

Soleno Therapeutics Inc in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLNO overviewAll 13F holders of SLNOFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of SLNO by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,237,550−100.0%Sold outHolders
Q1 20261,237,550$41.4M<0.1%+74,212+6.4%AddedHolders
Q4 20251,163,338$53.9M<0.1%+78,386+7.2%AddedHolders
Q3 20251,084,952$73.4M<0.1%+182,556+20.2%AddedHolders
Q2 2025902,396$75.6M<0.1%+286,660+46.6%AddedHolders
Q1 2025615,736$44.0M<0.1%+16,617+2.8%AddedHolders
Q4 2024599,119$26.9M<0.1%+58,823+10.9%AddedHolders
Q3 2024540,296$27.3M<0.1%+51,189+10.5%AddedHolders
Q2 2024489,107$20.0M<0.1%+322,086+192.8%AddedHolders
Q1 2024167,021$7.15M<0.1%+4,177+2.6%AddedHolders
Q4 2023162,844$6.56M<0.1%+110,291+209.9%AddedHolders
Q3 202352,553$1.55M<0.1%−2,095−3.8%ReducedHolders
Q2 202354,648$234.4K<0.1%+22,092+67.9%AddedHolders
Q1 202332,556$69.7K<0.1%00.0%UnchangedHolders
Q4 202232,556$64.0K<0.1%00.0%UnchangedHolders
Q3 202232,556$54.0K<0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q2 2022488,393$90.0K<0.1%+58,140+13.5%AddedHolders
Q1 2022430,253$95.0K<0.1%00.0%UnchangedHolders
Q4 2021430,253$176.0K<0.1%00.0%UnchangedHolders
Q3 2021430,253$397.0K<0.1%+18,185+4.4%AddedHolders
Q2 2021412,068$469.0K<0.1%−415,678−50.2%ReducedHolders
Q1 2021827,746$1.04M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.